the sun malaysia ipaper logo 150x150
Thursday, July 2, 2026
28.6 C
Kuala Lumpur
the sun malaysia ipaper logo 150x150

APG 2025: MPM expected to field more backup athletes

KUALA LUMPUR: The Malaysian Paralympic Council (MPM) is expected to field more backup athletes to carry the national challenge at the 2025 ASEAN Para Games (APG) in Nakhon Ratchasima, Thailand, from January 20 to 26 next year.

MPM president Datuk Seri Megat D Shahriman Zaharudin said the move is to ensure the grooming of future stars while preparing athletes for the 2027 APG in Malaysia and the 2028 Paralympic Games in Los Angeles (LA28).

“Preparations (for APG) are already in place, and the national para sports associations are ready. At the moment, we are focusing on identifying the winning teams and athletes who will be sent.

“The National Sports Council (NSC) also wants us to narrow the gap (with other countries) and to introduce new athletes. Insyaallah , this will be the future for APG 2027 and LA28,” he said.

Megat D Shahriman was speaking to reporters after the closing ceremony of Phase 2 of the National Para Sports Associations Empowerment Workshop, officiated by NSC Deputy Director-General (Management) Arrifin Mohd Ghani, here today.

Meanwhile, Arrifin expressed confidence that the three-day workshop, which began last Friday, would help empower and strengthen the governance of national para sports associations.

With good governance, he said, these associations could indirectly help develop capable athletes who can carry on the legacy of national para sports icons such as Datuk Abdul Latif Romly (athletics), Bonnie Bunyau Gustin (powerlifting), and Cheah Liek Hou (badminton).

STAY AHEAD OF THE CURVE

Join our community for instant updates and exclusive content.

Join Telegram Channel

Related


spot_img

Latest News

Bora Pharmaceuticals Completes Acquisition of MacroGenics’ Rockville Manufacturing Operations

TAIPEI, TAIWAN - Media OutReach Newswire - 2 July 2026 - Bora Pharmaceuticals Co., Ltd. ("Bora" or "Bora Group"; TWSE: 6472; OTCQX: BORAY) today announced the completion of its acquisition of the GMP manufacturing operations of MacroGenics, Inc. (NASDAQ: MGNX) including its biologics drug substance facility in Rockville, Maryland and an associated warehousing center in Frederick, Maryland, for total consideration of US $122.5 million through its wholly owned subsidiary Bora Biologics USA, LLC.. Upon closing, Bora signed a long-term CDMO Service Agreement with MacroGenics.

Most Viewed

spot_img
WC26

World Cup 2026

Updates, Fixtures, Results & Standings